CIDR: NCI Genome Wide Predictors of Survival in Colorectal Cancer
Anthropometry (2)
- HEIGHT - Height (cm) at Baseline (phv00431339.v1.p1)
- WEIGHT - Weight (kg) at Baseline (phv00431340.v1.p1)
Demographics (2)
- age_dx - Age at CRC diagnoses (phv00431331.v1.p1)
- sex - Gender of participant (phv00431328.v1.p1)
Disease Events (1)
- anydeath - All cause mortality (phv00431332.v1.p1)
Race and Ethnicity (2)
- ethnicity - Ethnicity of participant (phv00431330.v1.p1)
- race - Race of participant (phv00431329.v1.p1)
Other (30)
- ANALYTE_TYPE - Analyte type (phv00431351.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00431350.v1.p1)
- cancer_site_sum1 - Tumor site summary: colon vs.rectal (phv00431344.v1.p1)
- cancer_site_sum2 - Tumor Site summary: proximal/distal/rectal (phv00431345.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00431323.v1.p1)
- Diarrhea_bin - Whether the patients experienced grade 3+ Diarrhea across all cycles of treatment (phv00431336.v1.p1)
- GENOTYPING_CENTER - Name of the center which conducted genotyping (phv00431358.v1.p1)
- HistGrade - Histology Grade (phv00431348.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00431353.v1.p1)
- IS_TUMOR - Tumor status (phv00431352.v1.p1)
- NauseaVomit_bin - Whether the patients experienced grade 3+ nausea or vomiting across all cycles of treatment (phv00431335.v1.p1)
- Neuropathy_bin - Whether the patients experienced grade 3+ neuropathy across all cycles of treatment (phv00431338.v1.p1)
- Neutropenia_bin - Whether the patients experienced grade 3+ neutropenia across all cycles of treatment (phv00431337.v1.p1)
- NodesExamined - Number of Examined lymph nodes (phv00431346.v1.p1)
- NodesPositive_cat - Positive nodes, i.e., nodal status (phv00431343.v1.p1)
- PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00431354.v1.p1)
- Rash_bin - Whether the patients experienced grade 3+ Rash across all cycles of treatment (phv00431334.v1.p1)
- SAMPLE_ID - De-identified sample ID (phv00431349.v1.p1)
- SAMPLE_ID - Sample ID (phv00431325.v1.p1)
- stage2 - Disease stage (phv00431341.v1.p1)
- study - Participant study (phv00431327.v1.p1)
- SUBJECT_ID - De-identified subject ID (phv00431326.v1.p1)
- SUBJECT_ID - Subject ID (phv00431322.v1.p1)
- SUBJECT_ID - Subject ID (phv00431324.v1.p1)
- time_surv - Time to event or censoring (phv00431333.v1.p1)
- trx - Treatment Arm (phv00431347.v1.p1)
- Tstage - T stage (phv00431342.v1.p1)
- TUMOR_GRADE - Tumor grade of sample (phv00431356.v1.p1)
- TUMOR_STAGE - Tumor stage of sample (phv00431355.v1.p1)
- TUMOR_TREATMENT - Type of tumor treatment for sample (phv00431357.v1.p1)